CClinicalTrials.gg
CompletedNCT00884065Updated Mar 23, 2015Results posted

Effectiveness of Diacutaneous Fibrolysis in Painful Shoulder

An interventional study of Diacutaneous Fibrolysis and Diacutaneous Fibrolysis (placebo) in Shoulder Pain, sponsored by Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina. Completed at 1 site in Spain. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2015-03-23.

Sponsored by Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

While Diacutaneous fibrolysis (DF) has achieved promising results empirically, its effectiveness has not been tested in clinical trials. The investigators hypothesized that the use of DF in patients suffering from painful shoulder would increase the active mobility and reduce the pain during movement. To test the hypothesis a double blind (patient and investigator) randomized clinical trial was carried out in two public Primary Health Care Centres. Fifty patients were randomly allocated to two groups: the intervention group, who received a real DF session, and the control group, who received a placebo DF session.

Read the detailed description

Background and objectives:

Diacutaneous fibrolysis (DF) is a manual technique to treat the mechanical pain of the musculoskeletal system. While this technique has achieved promising results empirically, its effectiveness has not been tested in clinical trials. We aimed at evaluating the effectiveness of a single session of DF on pain and mobility in patients suffering from painful shoulder.

Subjects and methods:

This clinical trial took place in two public Primary Health Care Centres. Fifty patients were randomly allocated to two groups: the intervention group, who received a real DF session, and the control group, who received a placebo DF session. The degree of active mobility (flexion, abduction, extension, external and internal rotation), the pain in the hand behind back position and the participant's perception of the technique in terms of comfort and results obtained were measured.

02

Conditions studied

  • Shoulder Pain

Browse trials for

Keywords

  • Physiotherapy
  • Manual therapy
  • Painful Shoulder
  • Diacutaneous Fibrolysis
03

In context

Shoulder Pain

707 studies on the registry are indexed under Shoulder Pain; 152 are open to participants now.

This study's enrollment of 50 is below the median of 60 across 561 interventional studies indexed under Shoulder Pain.

Browse Shoulder Pain studies →

Lead sponsor

Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina is the lead sponsor of 158 studies on the registry; 20 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • over 18 years of age
  • being referred for treatment of painful shoulder (except for adhesive capsulitis)
  • not having been previously treated with DF

Exclusion criteria

Exclusion Criteria:

  • Damaged skin and/or cutaneous lesions in the shoulder area
  • History of shoulder surgery
  • Vascular abnormalities
  • Platelet antiaggregant therapy
  • Acute inflammatory condition of the shoulder (\<1 week)
  • Patients with a pending litigation or court claim
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Investigator)
Enrollment
50 participants (actual)

Study arms

  • Experimental
    Intervention Group

    The intervention group was treated with a single session of DF following the procedure as described by the authors.

    Other: Diacutaneous Fibrolysis

  • Placebo comparator
    Control Group

    The control group was treated with a single placebo session of DF.

    Other: Diacutaneous Fibrolysis (placebo)

Interventions

  • OtherDiacutaneous Fibrolysis

    The implementation of the technique consists of three consecutive stages: The first stage involves manual palpation, which is carried out by the hand that is not holding the hook, with the objective to find the area to be treated; the second, or instrumental palpation stage, is carried out by introducing the spatula of the hook together with the index finger of the palpatory hand to locate with precision the adherent connective fibers or fibrous corpuscles; the third, or fibrolysis stage, is the actual treatment. Here, a brief supplementary traction is carried out with the hook.

    Also known as: Manual therapy

  • OtherDiacutaneous Fibrolysis (placebo)

    The placebo was designed for this study and the stages of manual and instrumental palpation occur strictly at a superficial level. In the third stage, instead of fibrolysis a pinch of skin is hold with the thumb of the palpatory hand and the tip of the spatula, so that the patient feels the hook distinctly but without any action taking place on the deep tissular planes.

    Also known as: Manual therapy

06

What researchers measure

Primary outcomes

  1. Change in Active Flexion Movement After Intervention Minus Baseline

    A universal double armed goniometer was used to measure change in active flexión movement in the sagital plane with the elbow fully extended and the forearm in indifferent pronosupination (thumb forward)

    Time frame: Baseline and the same day (just after intervention)

  2. Change in Active Abduction Movement After Intervention Minus Baseline

    A universal double armed goniometer was used to measure change in active abduction movement in the scapular plane with the elbow in extension and the forearm in supination

    Time frame: Baseline and the same day (just after intervention)

  3. Change in Active extensión Movement After Intervention Minus Baseline

    A universal double armed goniometer was used to measure change in active extensión movement in the sagital plane with the elbow fully extended and the forearm in indifferent pronosupination (thumb forward)

    Time frame: Baseline and the same day (just after intervention)

  4. Change in Active External Rotation After Intervention Minus Baseline

    A universal double armed goniometer was used to measure change in active external rotation measured in the neutral position of the shoulder (arm pinned to the trunk), elbow flexed to 90º and the forearm in indifferent pronosupination (thumb forward)

    Time frame: Baseline and the same day (just after intervention)

  5. Change in Active Internal Rotation After Intervention Minus Baseline

    Change in active internal rotation was measured with the hand behind back test. The position achieved by the tip of the thumb was marked and with a flexible metric tape (always the same) the distance in centimetres between this mark and the inferior tip of the spinous process of C7 was measured; the shorter the distance, the better the mobility

    Time frame: Baseline and the same day (just after intervention)

Secondary outcomes

  1. Change in Pain in the Hand Behind Back Position After Intervention Minus Baseline

    An unmarked Visual Analogue Scale from 0 (no pain) to 100 (worst pain) millimeters was used. At baseline, participants registered the pain perceived in the position used to measure the internal rotation. After intervention, they registered the pain with the hand placed in the same position taking as a reference the mark in the first evaluation.

    Time frame: Baseline and the same day (just after intervention)

07

Results

Posted Apr 20, 2009

Participant flow

The study participants were recruited from two public services of primary health care of the Spanish National Health Service, one in Cornellà de Llobregat (Barcelona), the other in Ponteareas (Pontevedra), from June 2007 to January 2008.

Participant flow — Overall Study
MilestoneIntervention Group (Diacutaneous Fibrolysis)Control Group (Placebo)
Started2525
Completed2525
Not completed00

Outcome measures

SecondaryChange in Pain in the Hand Behind Back Position After Intervention Minus Baseline

An unmarked Visual Analogue Scale from 0 (no pain) to 100 (worst pain) millimeters was used. At baseline, participants registered the pain perceived in the position used to measure the internal rotation. After intervention, they registered the pain with the hand placed in the same position taking as a reference the mark in the first evaluation.

Time frame:
Baseline and the same day (just after intervention)
Reported as:
Mean · Millimeters
Change in Pain in the Hand Behind Back Position After Intervention Minus Baseline
MillimetersIntervention Group (Diacutaneous Fibrolysis)Control Group (Placebo)
Change in Pain in the Hand Behind Back Position After Intervention Minus Baseline-9.20 ± 15.16-7.48 ± 13.68
Statistical analysis
  • Intervention Group (Diacutaneous Fibrolysis) vs Control Group (Placebo) · t-test, 2 sided · p = >0.05 · Mean difference (final values): -1.72 · 95% CI -9.93 to 6.49
PrimaryChange in Active Flexion Movement After Intervention Minus Baseline

A universal double armed goniometer was used to measure change in active flexión movement in the sagital plane with the elbow fully extended and the forearm in indifferent pronosupination (thumb forward)

Time frame:
Baseline and the same day (just after intervention)
Reported as:
Mean · Sexagesimal Degrees
Change in Active Flexion Movement After Intervention Minus Baseline
Sexagesimal DegreesIntervention Group (Diacutaneous Fibrolysis)Control Group (Placebo)
Change in Active Flexion Movement After Intervention Minus Baseline9.48 ± 10.86-1.92 ± 9.03
Statistical analysis
  • Intervention Group (Diacutaneous Fibrolysis) vs Control Group (Placebo) · t-test, 2 sided · p = <0.01 · Mean difference (final values): 11.40 · 95% CI 5.72 to 17.08
PrimaryChange in Active Abduction Movement After Intervention Minus Baseline

A universal double armed goniometer was used to measure change in active abduction movement in the scapular plane with the elbow in extension and the forearm in supination

Time frame:
Baseline and the same day (just after intervention)
Reported as:
Mean · Sexagesimal degrees
Change in Active Abduction Movement After Intervention Minus Baseline
Sexagesimal degreesIntervention Group (Diacutaneous Fibrolysis)Control Group (Placebo)
Change in Active Abduction Movement After Intervention Minus Baseline7.88 ± 9.610.64 ± 8.69
Statistical analysis
  • Intervention Group (Diacutaneous Fibrolysis) vs Control Group (Placebo) · t-test, 2 sided · p = <0.01 · Mean difference (final values): 7.24 · 95% CI 2.03 to 12.45
PrimaryChange in Active extensión Movement After Intervention Minus Baseline

A universal double armed goniometer was used to measure change in active extensión movement in the sagital plane with the elbow fully extended and the forearm in indifferent pronosupination (thumb forward)

Time frame:
Baseline and the same day (just after intervention)
Reported as:
Mean · Sexagesimal degrees
Change in Active extensión Movement After Intervention Minus Baseline
Sexagesimal degreesIntervention Group (Diacutaneous Fibrolysis)Control Group (Placebo)
Change in Active extensión Movement After Intervention Minus Baseline2.08 ± 5.660.16 ± 6.44
Statistical analysis
  • Intervention Group (Diacutaneous Fibrolysis) vs Control Group (Placebo) · t-test, 2 sided · p = >0.05 · Mean difference (final values): 1.92 · 95% CI -1.53 to 5.37
PrimaryChange in Active External Rotation After Intervention Minus Baseline

A universal double armed goniometer was used to measure change in active external rotation measured in the neutral position of the shoulder (arm pinned to the trunk), elbow flexed to 90º and the forearm in indifferent pronosupination (thumb forward)

Time frame:
Baseline and the same day (just after intervention)
Reported as:
Mean · Sexagesimal degrees
Change in Active External Rotation After Intervention Minus Baseline
Sexagesimal degreesIntervention Group (Diacutaneous Fibrolysis)Control Group (Placebo)
Change in Active External Rotation After Intervention Minus Baseline0.76 ± 9.550.16 ± 5.24
Statistical analysis
  • Intervention Group (Diacutaneous Fibrolysis) vs Control Group (Placebo) · t-test, 2 sided · p = >0.05 · Mean difference (final values): 0.60 · 95% CI -3.81 to 5.01
PrimaryChange in Active Internal Rotation After Intervention Minus Baseline

Change in active internal rotation was measured with the hand behind back test. The position achieved by the tip of the thumb was marked and with a flexible metric tape (always the same) the distance in centimetres between this mark and the inferior tip of the spinous process of C7 was measured; the shorter the distance, the better the mobility

Time frame:
Baseline and the same day (just after intervention)
Reported as:
Mean · Centimeters
Change in Active Internal Rotation After Intervention Minus Baseline
CentimetersIntervention Group (Diacutaneous Fibrolysis)Control Group (Placebo)
Change in Active Internal Rotation After Intervention Minus Baseline4.50 ± 6.791.42 ± 3.12
Statistical analysis
  • Intervention Group (Diacutaneous Fibrolysis) vs Control Group (Placebo) · t-test, 2 sided · p = <0.01 · Mean difference (final values): 3.08 · 95% CI 0.08 to 6.09

Adverse events

Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Intervention Group (Diacutaneous Fibrolysis)—0/25 (0%)0/25 (0%)
Control Group (Placebo)—0/25 (0%)0/25 (0%)

Baseline characteristics

Age, Categorical
Age, Categorical(Participants)Intervention Group (Diacutaneous Fibrolysis)Control Group (Placebo)Total
<=18 years000.0
Between 18 and 65 years171532.0
>=65 years81018.0
Age, Continuous
Age, Continuous(years)Intervention Group (Diacutaneous Fibrolysis)Control Group (Placebo)Total
Mean56.76 ± 10.3360.8 ± 10.1258.78 ± 10.33
Sex: Female, Male
Sex: Female, Male(Participants)Intervention Group (Diacutaneous Fibrolysis)Control Group (Placebo)Total
Female161329.0
Male91221.0
Region of Enrollment
Region of Enrollment(participants)Intervention Group (Diacutaneous Fibrolysis)Control Group (Placebo)Total
Spain252550.0
Months of pain
Months of pain(Months)Intervention Group (Diacutaneous Fibrolysis)Control Group (Placebo)Total
Mean14.48 ± 16.2117.88 ± 27.5616.18 ± 22.44
08

Study locations

1 site
  • Catalan Institute of Health - Servei de Rhb Sant Ildefons
    Cornella de Llobregat, Barcelona 08940, Spain
09

References and documents

Publications

  • Barra ME, Lopez C, Fernandez G, Murillo E, Villar E, Raya L. The immediate effects of diacutaneous fibrolysis on pain and mobility in patients suffering from painful shoulder: a randomized placebo-controlled pilot study. Clin Rehabil. 2011 Apr;25(4):339-48. doi: 10.1177/0269215510385480. Epub 2010 Nov 15. PubMed 21078700 ↗
10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 23, 2015, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT00884065
Lead sponsor
Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina
Responsible party
Sponsor
First posted
Apr 20, 2009
Start date
Jun 2007
Primary completion
Jan 2008
Completion
Jan 2008
Results posted
Apr 20, 2009
Last update
Mar 23, 2015

Study contacts

Martín-Eusebio Barra-López, PT
principal investigator · Catalan Institute of Health
Carlos López-de-Celis, DO, PT
principal investigator · Catalan Institute of Health
Gabriela Fernández-Jentsch, PT
principal investigator · Servicio Gallego de Salud
Ernesto Murillo-Barrios, PT
principal investigator · Servicio Gallego de Salud
Edurne Villar-Mateo, PT
principal investigator · Catalan Institute of Health
Laura Raya-de-Cardenas, PT
principal investigator · Catalan Institute of Health
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2015. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion